Heat-directed gene targeting of adenoviral vectors to tumor cells

Cancer Gene Therapy

Volumn 7, Issue 12, 2000, Pages 1566-1574

  Brade, Anthony M ^a   Ngo, Duc ^b   Szmitko, Paul ^b   Li, Pei Xiang ^b   Liu, Fei Fei ^a   Klamut, Henry J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Adenoviral vectors; HSE; galactosidase

Indexed keywords

BETA GALACTOSIDASE; HEAT SHOCK PROTEIN 70; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HYPERTHERMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; XENOGRAFT;

EID: 0034490403     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700267     Document Type: Article

References (38)

1. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma
2. p53 Tumor suppressor gene therapy for cancer
3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex vires thymidine kinase gene
4. In vitro and in vivo targeting of gene expression to melanoma cells
5. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
6. Use of the stress-inducible grp78/ BiP promoter in targeting high level gene expression in fibrosarcoma in vivo
7. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: Activation by ionizing radiation or uptake of radioactive iododeoxyuridine
8. Spatial and temporal control of gene therapy using ionizing radiation
9. Hyperthermic treatment of malignant diseases: Current status and a view toward the future
10. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group
11. Factors influencing the thermosensitivity of two rodent tumors
12. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial
13. Regulation of the heat shock transcriptional response: Cross-talk between a family of heat shock factors, molecular chaperones, and negative regulators
14. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer
15. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
16. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells
17. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter
18. Heat-induced gene expression as a novel targeted cancer gene therapy strategy
19. Heat-inducible vectors for use in gene therapy
20. Analysis of heat shock element recognition by saturation mutagenesis of the human HSP70.1 gene promoter
21. Cooperative interaction of human HSF1 heat shock transcription factor with promoter DNA
22. Adenovirus-based expression vectors and recombinant vaccines
23. Differential thermal sensitivity of tumor and normal tissue microvascular response during hyperthermia
24. Control of delivered gene expression in chondrocytes using heat shock protein 70B promoter
25. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer
26. Heterogeneous patterns of constitutive and heat shock induced expression of HLA-linked HSP70-1 and HSP70-2 heat shock genes in human melanoma cell lines
27. Induction of the 72-kDa heat shock protein in human skin melanoma and squamous cell carcinoma cell lines
28. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1
29. Negative regulation of the heat shock transcriptional response by HSBP1
30. Molecular chaperones as HSF1-specific transcriptional repressors
31. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1
32. Transcriptional activity of heat shock factor 1 at 37 degrees C is repressed through phosphorylation on two distinct serine residues by glycogen synthase kinase 3 and protein kinases Calpha and Czeta
33. Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation
34. Response of heat shock element within the human HSP70 promoter to mutated p53 genes
35. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70
36. Thermotolerant cells show an attenuated expression of Hsp70 after heat shock
37. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector
38. Increased injection number enhances adenoviral genetic radiotherapy